Speakers include Prof. Jo Dukes McEwan, Head of Service, Professor in Small Animal Cardiology (University of Liverpool), Doctor Jennifer Schissler, Veterinary Dermatologist, Best Friends Animal Hospital & Urgent Care Unit (US), and Doctor Pascal Prélaud, Dermatologist, CEO ADVETIA Vet Hospital Center (France).
Participants will also be able to access to an immersive experience, the Vet Symposium Village, which includes the Live Stage, Vet Lab, Clinic Lounge, and Innovation Hub, all offering exclusive videos and lectures.
The event will be translated into Chinese, French, Spanish, Italian, Portuguese, Russian, and German, and a replay of the event will be available until the end of the year.
Dr. Jennifer Welser, Chief Medical Officer, Mars Veterinary Health, said: “It’s more critical than ever for pet professionals from various countries, fields, and perspectives to meet and share their knowledge.
"I look forward to participating in the Vet Symposium and speaking with my peers on topics ranging from mental health to advancements in quality medical care and retaining veterinary talent.”
https://digital-vetsymposium2022.com/
A 2021 German study reported the incidence of diarrhoea to be 18.5% and the most common disease observed in almost 14,000 neonatal calves examined on 731 dairy herds1.
Fencovis is indicated for the active immunisation of pregnant heifers and cows in order to stimulate the development of antibodies against bovine rotavirus, bovine coronavirus and E. coli expressing F5 (K99) adhesin and to increase the level of passive immunity of calves against neonatal diarrhoea caused by bovine rotavirus, bovine coronavirus and E. coli expressing F5 (K99) adhesin.
Boehringer says that in calves fed with colostrum and milk from vaccinated cows, these antibodies have been demonstrated to prevent diarrhoea caused by rotavirus and E. coli F5 (K99) adhesin and reduce the incidence and severity of diarrhoea caused by coronavirus.
Viral shedding in calves infected by rotavirus and coronavirus was also reduced by Fencovis.
Findlay MacBean, Business Head Livestock at Boehringer Ingelheim UK & Ireland, said: “We are delighted to announce the launch of Fencovis, the first vaccine that is licensed to prevent calf scour caused by Rotavirus and E. coli F5 (K99), and also reduce the incidence and severity of scour associated with coronavirus infection. ”
Fencovis is a suspension for injection which uses a non-oil adjuvant. It comes in a variety of presentations including a single dose pack.
Reference
Frontline wormer for cats contains praziquantel and pyrantel embonate, and for dogs it also contains febantel.
According to the company, Frontline Wormer is effective agains all types of intestinal worms found in the UK: roundworms, tapeworms, hookworms and whipworms.
It is presented as a palatable tablet which can be given as a treat without food, or mixed with food.
The press release from the company says the new product "gives pet parents an easy way to worm their cats and dogs".
"Pet parents?"
Someone please pass me the sick bag.
If I get one more press release describing cat or dog owners as 'pet parents", so help me god I will turn up at the press office and chain myself - naked - to the photocopying machine in protest.
It's a ghastly, patronising, cloying way to refer to people who own an animal, besides which, if I really was the parent of a pet, I would expect to be serving time at His Majesty's pleasure.
Frontline Wormer is available in packs of two tablets for 3 pet sizes.
As an AVM-GSL-licensed product, it can be sold off the shelf.
Common ‘Pet Dangers’ include:
The poster also reinforces the importance of S.P.E.E.D when dealing with poisoned pets:
To get your free poster, visit https://www.tvm-uk.com/pet-dangers-order-free-display-materials-for-your-practice/ or email help@tvm-uk.com.
The authors say that the prognosis for dogs with stage II Kiupel high-grade cutaneous mast cell tumours has historically been considered poor.
However, the removal of metastatic regional lymph nodes in more recent research has been associated with a better outcome in canine cutaneous mast cell tumours.
For this study1, dogs with a histological diagnosis of overt lymph node metastasis that underwent lymphadenectomy (n = 31) were compared with those with a cytological diagnosis of regional lymph node metastasis, that did not undergo excision (n 18).
The study was a multi-institutional retrospective cohort study, using electronic medical records from four European institutions to identify dogs for inclusion.
The study found that dogs with Kiupel high-grade cutaneous mast cell tumours undergoing lymphadenectomy of HN3 lymph nodes as part of their primary surgery in addition to adjuvant medical treatment had a significant improvement in time to progression and survival time compared with those dogs not undergoing the procedure.
Lack of lymphadenectomy was the only variable significantly associated with a higher risk of nodal progression.
Dogs underwent lymphadenectomy of one peripheral lymph node in most cases.
The authors says that a higher number of lymph nodes or the removal of intracavitary lymph nodes might be associated with an increased incidence of postoperative morbidity.
They add that the findings warrant further exploration of the effect of surgical extirpation of metastatic sentinel lymph nodes and the number of lymph nodes removed on outcome in dogs with Kiupel high-grade cutaneous mast cell tumours.
Nicola Di Girolamo, Editor of JSAP said: “It is really encouraging to see collaborations from multiple institutions like the study presented here.
"Including multiple institutions in a retrospective cohort study, does not only ensure a higher sample size, but also ensure a higher generalisability of the results.
"Meaning that it is more likely that the differences observed in this study are also going to be observed at different practices and with different clinicians.”
https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13525
MSD says that no other UK-licensed BRD vaccine can be administered earlier in life and that the onset of immunity for BRSV is 6 days (for calves vaccinated from the day of birth onwards) and 5 days (for calves vaccinated from the age of one week onwards).
Onset of immunity for Pi3V is one week after vaccination. The duration of immunity is 12 weeks for both viruses.
From a practical standpoint, the new license means Bovilis Intranasal RSP Live can now be used on farm at the same time as other early life interventions associated with newborn calves – for example, colostrum/first milk feeding, navel management, tagging, jacketing and necessary pen movements.
Additionally, Bovilis Intranasal RSP Live can be used up to six hours after mixing with the solvent, which MSD says is the longest of all the available intranasal vaccines for these pathogens.
The vaccine is supplied as a nasal suspension product that doesn’t need a specific applicator – although for maximum flexibility an easy-clean injector and nozzle kit is available for vaccinating multiple animals.
The vaccine is available in 5x1 dose, 5 dose and 5x5 dose packs.
The courses are:
MMI Manager Lisa Quigley commented: “I am really proud of this new tranche of training.
"Whereas our previous training has focused on the individual experience, for example, mental health awareness and resilience, these new courses recognise that individual instances of poor mental health and wellbeing can often be caused by systemic issues – whether that’s a poor workplace culture where bullying and incivility thrive, or discrimination on account of someone’s protected characteristics.
The full range of courses, including the dates and times and details on how to register, can be found at www.vetmindmatters.org/training
Feedback about any of the courses can be sent to info@vetmindmatters.org
The 'Room For Rabbits' campaign follows research in which 38% of vets said they think rabbits’ environment is the most neglected welfare need1, with over a quarter of the UK’s rabbits being kept in inadequate housing conditions, and almost half of them living alone2.
The RAW survey also found that 90% of vets believe that rabbits’ welfare in the UK is improving3.
Room for Rabbits will throw a spotlight on rabbits’ environment, with a variety of initiatives during RAW including vet blogs and videos on how to adapt bunnies’ housing for all seasons, boredom buster ideas, a competition to encourage owners to create a RAW ‘gold standard’ environment, and downloadable packs containing resources for practices to create their own RAW campaigns.
Holly Castle, Senior Brand Manager at Burgess Pet Care, RAAG member and organisers of RAW, said: “We are delighted that RAW continues to have a positive impact, with our survey showing that 90% of vets believe that the welfare of the UK’s rabbits is improving - but there is always more than we can do.
“Since the previous RAW campaign, we have successfully launched RAAG, which recognises that the welfare of these wonderful creatures needs to be high on the agenda year-round.
"By bringing together the expertise of the RAW partners, RAAG is focused on encouraging everyone involved with rabbits to support the first Good Practice Code for rabbits’ welfare in England to ensure it becomes enshrined in law.
"One of the ways to achieve this is through initiatives like RAW, which is the UK’s largest welfare campaign of its kind.
“We recognise that vets’ practices were really stretched last year due to the Covid-19 pandemic, which meant it was difficult to support campaigns like RAW.
"However, following a surge in demand for rabbit ownership in the UK during the past two years, it is vitally important that we educate more owners than ever before and continue to help improve rabbits’ welfare."
“The veterinary community plays a hugely important role in ensuring that owners have access to the right information, and we are urging practices to throw their support behind this year’s RAW to ensure that we reach as many owners as possible.
Professor Ian Ramsey, Past President of the BSAVA, which endorses RAW, said: "The BSAVA is once again delighted to support RAW and the theme of this year’s campaign.
"Rabbits remain one of the most misunderstood pets in the UK, but we are confident that vets across the UK will again show their support for this important campaign to improve the lives of pet rabbits.”
The RAAG is encouraging vets’ practices to sign up to receive updates about RAW at https://www.rabbitawarenessactiongroup.co.uk/raw-pack-reminder/.
Downloadable RAW vet packs will also be available from 6th June.
The company says the results of the survey of puppy dental health will be shared with industry experts to help advance understanding and evaluate the future impact on veterinary practices.
Veterinary professionals can also sign up for a free webinar on puppy dental disease led by Head of the Dentistry and Oral Surgery Department at the Royal (Dick) Vet School, Ingrid Tundo on 28th April at 7.30 pm at https://veterinarywebinars.com/register/puppy-dentistry-malocclusion.
Cat Henstridge MRCVS, who is fronting the campaign said: “I’m very pleased to be helping to raise awareness of the VisioCare Puppy Tooth Census and this important issue.
"It is so important for all of us in the profession to be helping to identify disease patterns and the scale of the problem. It also provides us with a great opportunity to involve our clients and start discussions about the importance of good dental care.”
VisioCare says the Puppy Tooth Census only takes a few minutes to complete and can be filled in for individual cases or healthy puppy mouths.
Every veterinary respondent will be given a free pack of educational materials to use in the consulting room, including state-of-the art digital animations and dental images that can be used to enhance client communication around the topic, together with explainer videos and puppy owner fact sheets and leaflets.
In addition, each month for the next three months, responses will be entered into a prize draw for the chance to win a £50 John Lewis gift voucher.
For further information or to complete the census for a case, visit: http://www.visiocareservices.co.uk/puppy-tooth-census.
Vets for Ukrainian Pets will cover the treatment costs of up to five dogs, cats, horses or other pet animals, up to 250 Euros per animal, for acute care and medication, rabies and other vaccinations as well as microchipping and medical examination required for safe passage through the EU.
The initiative is being funded by HSI, with support from Mars.
It is being run collaboration with Federation of Veterinarians in Europe and the Federation of European Companion Animal Veterinary Associations.
Reimbursements for participating veterinary surgeons will be available wherever the FECAVA has members, including in the United Kingdom, Germany, Italy, Romania and Poland, as well as Ukraine.
Ruud Tombrock, executive director of HSI/Europe, said: “In Europe’s biggest refugee crisis since WWII, millions of Ukrainians have had to take the decision to leave their country and flee the war.
"Along with a few possessions, many are also taking their pet animals, who they cherish as family members.
"The trauma of war as well as the stress of the evacuation journey, can make animals vulnerable to a variety of illnesses and so HSI’s Vets for Ukrainian Pets program aims to eliminate barriers to accessing veterinary care for the pets of refugees.
"It will provide a much-needed safety net for those families fleeing with their beloved pets so that at no point they feel compelled to leave their pets behind due to concerns about being able to care for them.”
Vets for Ukrainian Pets will run until 21st May 2022 and is open for all licensed veterinary clinics to apply throughout Europe, whether owned privately or as part of a corporate group.
Veterinary surgeons who want to join the program should visit apply.vetsforukraine.com.
Prior to becoming COO, Tim was Managing Director of three referral hospitals owned by Linnaeus – Davies Veterinary Specialists, London Veterinary Specialists and Southfields Veterinary Specialists – and a number of its primary care sites.
Prior to joining Linnaeus, Tim worked in Iceland, where he was a vet for the Icelandic Government.
On his return from Iceland in 2016, he joined Village Vet and then progressed into a range of regional management and practice leadership positions across the industry.
Tim said: "I am proud to be part of our wonderful, unique industry that, although currently facing a number of challenges, continues to make such a difference to the lives of our patients and their owners every day.
“In my first vet role in mixed practice, I was fortunate to receive brilliant support, guidance and encouragement from my team.
"Since then, I have always wanted to do the same for my colleagues, particularly those who are just starting their careers.
“I have used my experience within the veterinary profession to support some fantastic teams at Linnaeus.
"Becoming COO is an honour and opportunity that will enable me to help even more people across the business.”
239 members took part in the survey, 46% from independent practices and the remainder in corporates.
60% were clinical directors, partners or owners and 30% were in an assistant or associate role.
Other than COVID, the main barriers to providing EMS were not having enough time or energy to support a student (approx 46%), too much work to do (approx 37%), not enough veterinary staff (approx 33%), and not having housing for a student (approx 19%).
The top four things which respondents felt would improve the quality of EMS were a clearer understanding of students' needs (92%), longer placements to allow more confidence to build (84%), free training on how to coach students (78%) and more resources to help students and mentors (73%).
It was also suggested that because universities are effectively asking vets to do their job for them, they should be offering free CPD to help all vets deliver EMS effectively.
To enhance the EMS experience, SPVS has produced a pre-placement preparation form which outlines the practice requirements, an EMS induction form to help students consider their priorities and expectations for the placement and the a Skills Matrix which provides a framework to structure learning objectives and record progress.
For the full survey report and to access the resources, visit the SPVS website https://spvs.org.uk/ems-free-resources-gateway/
Felpreva contains emodepside and praziquantel, with tigolaner, a novel bispyrazole active ingredient.
Felpreva is licensed for treatment of cats with, or at risk from, mixed parasitic infestations/infections.
Vetoquinol points to a survey revealed conducted last year in which 43% of cat owners said that giving parasite protection to their cat makes them feel guilty, stressed, or worried1.
Felpreva provides an option to reduce the frequency of treatments, lessening stressful interactions between owners and their cats.
Vetoquinol says that with Felpreva’s convenience and longer-lasting flea and tick protection, it aims to help support compliance and thus improve the wellbeing of feline companions.
Helen Hunter, Senior Product Manager at Vetoquinol UK, said: “The launch of Felpreva is a truly proud moment for Vetoquinol, demonstrating our expertise, passion, and commitment to innovation in this essential category of companion animal medicine.
"It will allow us to safeguard the health of cats by bringing longer-lasting protection, convenience, and ease of use – for both pet owners and veterinary professionals.
"At a time when vets are treating more pets than ever before, the need for a breakthrough endectocide solution like Felpreva has never been greater.”
Felpreva is in wholesalers now.
For more information, contact your local Vetoquinol representative.
The two cases came from Bristol and Kingsbridge, Devon, taking the total number this year to five countrywide.
David Walker, American, RCVS and EBVS European specialist in small animal internal medicine, who leads the team at Anderson Moores, said: “We’re very sad to confirm two further cases of CRGV.
"Unfortunately, we find ourselves at the time of year when cases are most commonly identified."
There were 47 confirmed cases in 2020 and 28 in 2021.
The two new cases bring the total to 284 since the disease was first detected in the UK in 2012.
Anderson Moores has launched a website dedicated to Alabama Rot, which offers advice and information for owners and veterinary professionals, including a live map of confirmed cases across the UK: www.alabama-rot.co.uk.
For the research, Purina questioned 1535 current and potential dog owners using validated scales assessing depression, anxiety, happiness, attitude and commitment toward their pet, and perceived social support.
67% of participants said they felt that COVID had had an emotional impact on them.
One-third of participants also felt that their health had been impacted by the pandemic, while 45% had experienced a financial impact.
However, it was found that dog owners had higher perceived level of social support and lower depression scores.
Francois Martin, M.A., Ph.D., applied behaviour and welfare research section leader at Purina and lead Purina scientist on the project said: "Our research showed that dog owners fared better from a social support and emotional standpoint during COVID than people who like dogs but didn’t own one during the pandemic.
"Our work adds to a growing body of evidence demonstrating the power of the human pet bond, especially in times of stress.”
Libby Sheridan MVB MRCVS, Purina Scientific Affairs Manager for the UK and Ireland said: "The research aimed to build on prior evidence that suggests that dogs can contribute to their owner’s positive affective state - a psychological term describing when people are in generally positive frame of mind like excited, enthusiastic, and inspired.
"Purina also set out to gain a better understanding of whether the power of the pet-owner bond continued to persist during the pandemic. Not only was the effect of dogs shown to be positive, it was also measurable and statistically significant.”
Purina says the results also provide an opportunity to reflect on the important contribution of veterinary professionals, many of whom continued to work throughout the pandemic to provide much needed services.
For full results, visit: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0260676
Vets4Pets says research has shown that 28% of cats between 11 and 15 years show at least one clinical sign of cognitive dysfunction, with this figure increasing to 50 per cent in cats over 15 years of age1.
The prevalence in dogs is also reported to be significant, with some estimates indicating that 28% of 11- to 12-year-old dogs and 68% of 15- to 16-year-old dogs are showing clinical signs of the condition2.
A 2010 study, which used data from pet owner questionnaires, also estimated that the prevalence of cognitive dysfunction was 14.2% in dogs over the age of eight years, yet only 1.9% of older dogs were clinically diagnosed with the condition3.
The survey of 2,000 owners, which was conducted for Vets4Pets by market research company OnePoll, found that half would not be confident identifying the early indicators of cognitive dysfunction, namely: confusion, anxiety, restlessness, and a decreased desire to play.
62% said they would put any significant behavioural changes in their pet down to them getting old, and more than three in five admitted they can find it difficult to understand the signs of when they should be taking their pet to visit the vet.
Up to 33% delay taking their pet to the vet as they worry they might get bad news
However, 35% said they have or will increase the number of routine visits to the vets as their pet gets older.
Dr Huw Stacey, Director of Clinical Services at Vets4Pets said: “It is only natural that many pet owners can have apprehensions about bringing their pet along to the vets, which is just a testament to how much they care.
"But this is also why it’s incredibly important that we as an industry have the expertise and training needed to properly support pet owners with this diagnosis."
“Our ultimate goal is to help educate vets and nurses across the nation and empower them in their decision making when diagnosing elderly pets, as well as helping pet owners to care for their pets so they live a longer, healthier and happier life.”
As part of its campaign, Vets4Pets has sponsored a free CPD webinar in which Dr Sarah Heath, RCVS and European Veterinary Specialist in Behavioural Medicine (pictured right), considers ways in which the veterinary profession can improve the detection of this condition, enabling them to offer practical advice and support for senior pets and their owners.
The recording consists of a 45-minute webinar and a 15-minute Q&A session which will be available for anyone to watch for a year.
To watch the webinar, visit: https://vimeo.com/684610594/3d9d258bcb.
References
The study, titled The Veterinary Employment, Engagement and Retention Study (VEER), opened this week and aims to collect data from thousands of veterinary professionals across the United Kingdom and beyond.
Dr Dermot McInerney (pictured right), VetX Head of Research and Partnerships, said: “We will use the data collected to understand the factors influencing career happiness and how they impact on talent attraction and retention.
"We want to share this information with as many people as possible so we can work together to create a better, more sustainable situation for both employers and employees in veterinary practice.”
The study findings will be published later in 2022 and made available to all industry stakeholders.
All participants will receive a special report of the results with customised career advice, and be entered into a weekly draw to win a prize.
To take part in the survey, visit: www.vetxinternational.com/veer.
The new Flock Health Checklist is designed to helps practitioners assess performance across the three crucial time periods and two key management processes which have an impact on the success of sheep enterprises.
Dr Kat Baxter-Smith, veterinary adviser with MSD Animal Health said: “We have developed this new performance checklist drawing on specialist sheep vet working experiences, clinical research studies, economic data and industry recommendations.
"For example, the pre-breeding period is a great time to make sure ewes and rams are as fit and healthy as possible.
"Good practice and preparation in this area will go a long way to minimising stress and problems during a busy lambing period.”
Late pregnancy and lambing period is also a vital time – and is the busiest few weeks on any sheep farm.
Kat added: “Having pre-agreed protocols for this important period in the sheep farming calendar – and keeping a record of issues that arise – will go a long way to making sure subsequent lambing seasons go as smoothly as possible.”
Growth, weaning and sale is the third crucial time period and the Flock Health Checklist incorporates an additional series of audit-based questions designed to pinpoint system strengths and weaknesses.
The Flock Health Checklist also enables vets to ask a series of questions covering two key management processes: disease management and biosecurity; and how flock performance is currently monitored.
Kat said: “Working through a series of 10 questions within each of the three crucial time periods and two key management processes – designed to tease out where a sheep unit is in terms of accepted best management practice – allows vet and farmer to quickly pinpoint any areas needing attention.
"What’s more, repeating the checklist every six or 12 months is a great way to keep things on track, allowing both parties to montor performance against agreed targets.
“Similar types of checklist have been available to dairy youngstock rearing units and beef suckler herds for a couple of years now, with several vets reporting that these tools have proved integral to their productivity improvement work with farmer clients.
"Use of this checklist-based approach is also helping better implementation of preventative health practices such as vaccination. We hope this latest tool will help the GB sheep industry similarly.”
For further information, contact your local MSD Animal Health account manager.
Virbac points to research showing that MCTs are the most common form of skin cancer in dogs, accounting for up to 21% of skin cancer cases1.
This, says the company, means that understanding the challenges surrounding mast cell tumour diagnosis, work up (including the various prognostic panels) and treatment selection for mast cell tumour cases is vital.
The session, entitled ‘Fundamentals of Mast Cell Tumour Management’, will conclude with a review of Stelfonta, walking through cases and how to get the best results.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "We know that vets are facing webinar fatigue.
"We therefore hope that this brand new style of online learning on one of the most common canine cancers will be more engaging, whilst still delivering high quality CPD."
To register for the live event, visit: https://tinyurl.com/mct-masterclass
For more information, speak to your Virbac Territory Manager, or visit vet-uk.virbac.com/stelfonta
Dr Mostert admitted to his conviction but denied that it rendered him unfit to practise as a veterinary surgeon.
He also admitted not disclosing his conviction to the RCVS but denied that it amounted to dishonesty or was misleading and that failing to do so amounted to disgraceful conduct in a professional respect.
The Committee first considered whether Dr Mostert’s conviction affected the public interest, which included the need to maintain public confidence in the profession by upholding proper standards of conduct and behaviour for members of the profession.
The Committee noted that the conviction involved dishonesty relating to false statements about the value of goods sent to the USA.
The Committee felt that a conviction for a serious offence involving dishonesty would have a negative impact on public confidence in the profession, and that its reputation would be damaged if proper standards of conduct and behaviour were not upheld.
The Committee also noted that as the products that Dr Mostert imported into the USA were not labelled as coming from a foreign market and were not labelled as needing to be administered by a vet, his conviction also related to animal safety, as anyone who accessed the medications could believe that it was safe for them to be given to an animal.
The Committee then considered Dr Mostert’s failure to declare the conviction to the College on three separate occasions.
Dr Mostert testified that, at the time, he did not believe he had to disclose his conviction as it occurred in a country where he had not practised as a veterinary surgeon.
He also said he had not taken the time to read and interpret the application form accurately.
However, the Committee considered that the wording around convictions on the application and annual renewal forms is very clear and that, as a veterinary surgeon, Dr Mostert would be familiar with such documents.
The Committee considered that it was inconceivable that an experienced veterinary surgeon, making a declaration of this kind to his regulator, would not have understood that a serious conviction in the USA, dating from June 2017, was a conviction that he was obliged to disclose.
The Committee therefore found Dr Mostert’s failures to declare his conviction dishonest.
Judith Way, Chairing the Committee and speaking on its behalf, noted that in deciding upon the appropriate sanction, the case did not involve any actual harm to an animal or human and that Dr Mostert had had a long and otherwise unblemished career.
However, a key aggravating factor was that the action that led to the conviction resulted in financial gain through the creation of a business enterprise and that Dr Mostert falsely declared the value of goods.
The extent of any financial gain was not known to the Committee, but the business operated on the basis that false declarations were repeatedly made.
Judith said: “After careful consideration the Committee has concluded that in all the circumstances, a lengthy period of suspension would properly reflect the gravity of the case and satisfy the public interest. The Committee has decided that the appropriate length of suspension is one of 18 months.”
The Committee’s full findings can be viewed at www.rcvs.org.uk/disciplinary
Humanimal Trust is the only organisation in the UK with the sole purpose of progressing One Medicine, driving collaboration between vets, doctors, nurses and researchers so advances in both human and animal medicine can be achieved faster.
The seminar, entitled One Medicine in Action – Awareness, Collaboration and Change, follows on from the Trust’s inaugural symposium last year when a roadmap was created on how to develop closer links between human and veterinary medical and research professionals.
This year’s event will look at ways to put the roadmap into action through awareness raising, increased collaboration and change.
Professor Roberto La Ragione, Chair of Trustees at Humanimal Trust (pictured right), said “We know that when animal and human health professionals and scientists come together, great things happen.
"Last year’s symposium, which was part of our ‘Stronger Together’ campaign, was a huge success.
"It drew an audience from across the UK and Europe, as well as Chile, the United States, Singapore and Australia.
“Not only did it provide a real opportunity to explore ways to achieve more ethical and fair medical progress for all, but it also allowed connections to be made and relationships to be forged that wouldn’t otherwise exist.”
Miss Anna Radford, a Consultant in Paediatric Surgery at Hull University NHS Trust and Leeds Children’s Hospital, who is speaking at the seminar in May, said: “I was introduced to a diagnostics company working in the animal medical care field at last year’s symposium and through them, we have set up a new collaboration with the aim of determining whether this sort of diagnostic technology developed with companion animal medicine in mind, could potentially also be useful to help diagnose urinary, joint and cerebrospinal fluid infections in a busy NHS hospital setting.”
Other speakers at this year’s event include Dr Deborah Thomson, Founder and President of One Health Lessons, an organisation that inspires children and adults around the world to value the interconnection between human health and the health of the environment, plants and animals.
Dr Simon Doherty, a Senior Lecturer at the Institute of Global Food Security at Queen’s University in Belfast will highlight organisations that are successfully working together to improve the sustainability of dairy, meat and fish production to feed a growing global population, as well as the opportunities that exist for collaboration within the agri-food sector.
Dr Doug Brown, CEO of the British Society for Immunology, will share some of the most notable examples of joined-up approaches in human and animal health research from across the Society’s membership, with a particular focus on veterinary immunology.
The seminar, which will run from 2pm until 5.15pm BST, will end with a panel Q&A session, chaired by Humanimal Trust Trustee and Consultant Respiratory Physician at the University Hospital Southampton NHS Foundation Trust, Dr Ben Marshall.
Attendance is free and registration is now open to all human and veterinary medical professionals and students, and the allied health and scientific disciplines.
To find out more and register, visit www.humanimaltrust.org.uk
Horiba says subclinical hypocalcaemia (SCH) is a significant and under-diagnosed metabolic problem in dairy cattle affecting up to 50% cows annually.
After lactation, total calcium levels in the cows’ blood drop which can lead to sub-optimal health and yield.
The webinar will be presented by James Husband BA, VetMB, DipECBHM, DCHP, MRCVS, who will offer the benefit of his research and experience on the subject.
At the end, there'll be a Q&A session.
During the webinar, Horiba will also introduce its patient-sideLAQUAtwin Ca-11C pocket meter, which measures blood ionised calcium levels fast and is currently on special offer until 30th June 2022.
To register, visit: https://register.gotowebinar.com/register/6274625209458361872
In addition to working as a clinician in private practice and for charity, Gudrun has worked in several veterinary-related roles in industry, both in management and as a consultant, as well as being the Chair for the British Veterinary Association’s Good Veterinary Workplace Working Group.
In the new role, Gudrun will work support the implementation of the British Veterinary Association’s Good Veterinary Workplaces Code across the business.
Gudrun said: “Having been heavily involved in the work leading up to the Good Veterinary Workplaces Code during my time at the British Veterinary Association, I can fully relate to the many pressures that veterinary workplaces are currently under.
"Through supportive action and using evidence-based tools, I believe we can make a positive and lasting difference.
“It’s an honour to join Vets4Pets as we begin to implement its many commitments to improving the industry.
"I am excited to work towards a positive future for veterinary workplaces and being able to work with Vets4Pets to build a well-resourced and accessible tool for practices to implement good veterinary workplaces will help our practices to attract and retain the best clinical talent.”
The company says more and more CT scanners are being used in general practice, but many teams have been telling them they're not sure if they're using their scanner optimally, or that only some of the team are confident in using it.
The online training aims help teams get the best diagnostic use of CT
The first of the sessions, on 15th June, will cover the indications and benefits of CT in small animal practice.
The second on 22nd June will look at how and when to perform CT reconstructions.
Manuel Pinilla, VetCT Supporting Radiologist and Director of Quality Assurance (pictured right), will be delivering the talks.
Manuel said: “We are seeing a rapid increase in the use of CT in first opinion practice.
"We know CT can provide vital diagnostic information in addition to the more traditional modalities of x-ray and ultrasound.
"However, it can be challenging to optimise the diagnostic capability.
"We’re keen to support veterinary teams to help them get the most out of their machine and do the best for their patients and the owners.”
To register for the training, visit: https://welcome.vet-ct.com/ctcpdwebinars
Suicide postvention is the response and provision of support after a suicide.
It aims to support recovery, and to prevent further adverse outcomes in the aftermath including the prevention of further deaths by suicide.
The new guidance is intended for people who have been affected by the suicide of a veterinary professional, people who support those who have been affected, and for managers and leaders in veterinary workplaces who are working to prevent suicide.
The guidance examines veterinary workplace considerations after a suicide, including immediate aftermath and longer term.
It also covers communication, including talking both with colleagues and clients, and publicly on social media and elsewhere.
It finishes with a checklist of actions for veterinary workplaces affected by suicide considering immediate, short term, and ongoing actions for support and postvention.
As well as providing this guidance, Vetlife can provide individualised support to practices and individuals who have experienced a suicide through its Postvention Service.
If you are a UK veterinary professional who has been affected by suicide or wants support for a veterinary workplace, contact 0303 040 2551.
You can download the guidance here.